Author

Stephen M. F. Jamieson

University of AucklandORCID 0000-0002-5485-9211Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Benjamin D. DicksoniD· 1 shared Cho Rong HongiD· 1 shared David M. ShacklefordiD· 1 shared Jacqueline RossiD· 1 shared Jagdish Kumar JaiswaliD· 1 shared Longjin ZhongiD· 1 shared Lydia P. LiewiD· 1 shared Michael P. HayiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Benjamin D. DicksonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systemic CYP3A inhibition by ritonavir enables selective targeting of hypoxic tumour cells by prodrugs of DNA-PK inhibitors

Cho Rong Hong, Benjamin D. Dickson, Lydia P. Liew, Way Wua Wong, Jagdish Kumar Jaiswal, Stephen M. F. Jamieson, Jacqueline Ross, Longjin Zhong, David M. Shackleford, William Robert Wilson, Michael P. Hay

This paper shows that ritonavir enhances the hypoxia-targeted delivery of DNA-PK inhibitors, improving radiosensitization of tumors while sparing normal tissue.

bioRxiv · Feb 14, 2026 · PreprintPharmacology & Toxicology